Cholinergic Adverse Effects of Cholinesterase Inhibitors in Alzheimer's Disease: Epidemiology and Management

ISSN： 1170-229X

Source： Drugs & Aging, Vol.18, Iss.11, 2001-01, pp. : 853-862

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cholinesterase Inhibitors for Alzheimer's Disease

By Grutzendler J. Morris J.C.

Drugs, Vol. 61, Iss. 1, 2001-01 ,pp. : 41-52

Adis International

Access to resources Recommend Favorite

Cholinesterase Inhibitors in the Clinical Management of Alzheimer's Disease: Importance of Early and Persistent Treatment

By Seltzer B

The Journal of International Medical Research, Vol. 34, Iss. 4, 2006-08 ,pp. : 339-347

Field House Publishing

Access to resources Recommend Favorite

Effects of Cholinesterase Inhibitors on Behavioural Disturbances in Alzheimer's Disease: A Systematic Review

By Grimmer Timo Kurz Alexander

Drugs & Aging, Vol. 23, Iss. 12, 2006-01 ,pp. : 957-967

Adis International

Access to resources Recommend Favorite

Pharmacodynamic-Tolerability Relationships of Cholinesterase Inhibitors for Alzheimer's Disease

By Imbimbo B.P.

CNS Drugs, Vol. 15, Iss. 5, 2001-01 ,pp. : 375-390

Adis International

Access to resources Recommend Favorite

Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimers Disease

By Jönsson L.

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1025-1037

Adis International

Access to resources Recommend Favorite